Boenning & Scattergood’s AstraZeneca AZN Stock Holding History

Boenning & Scattergood’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$939K	Buy	7,078 +563	+9%	+$70.6K	0.15%	160
2022 Q3	$715K	Sell	6,515 -488	-7%	-$61.9K	0.15%	165
2022 Q2	$925K	Sell	7,003 -75	-1%	-$9.84K	0.17%	142
2022 Q1	$939K	Buy	7,078 +897	+15%	+$108K	0.15%	160
2021 Q4	$720K	Buy	6,181 +42	+0.7%	+$4.94K	0.12%	202
2021 Q3	$737K	Buy	6,139 +1,320	+27%	+$154K	0.13%	187
2021 Q2	$577K	Buy	4,819 +10	+0.2%	+$1.1K	0.1%	213
2021 Q1	$478K	Buy	4,809 +75	+2%	+$7.54K	0.09%	240
2020 Q4	$473K	Buy	4,734 +529	+13%	+$56K	0.1%	212
2020 Q3	$461K	Buy	4,205 +400	+11%	+$44.5K	0.11%	198
2020 Q2	$402K	Buy	+3,805	New	+$393K	0.11%	203

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

AWA

Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Boenning & Scattergood's AZN Position: Q4 2022 in Review

Boenning & Scattergood increased its AstraZeneca (AZN) stake by 8.6% in Q4 2022, buying an estimated $70.6K and bringing the position to 7,078 shares worth $939K. The position accounts for 0.15% of the portfolio, ranked #160.

Boenning & Scattergood first reported a position in AZN in Q2 2020 and has held it in 11 quarters since. 1,061 funds tracked by Wall St. Rank hold AZN as of Q4 2022.

Boenning & Scattergood held 7,078 shares of AstraZeneca worth $939K as of Q4 2022.
Boenning & Scattergood bought 563 AstraZeneca shares in Q4 2022, an estimated $70.6K.
AstraZeneca made up 0.15% of Boenning & Scattergood's portfolio in Q4 2022, its #160 holding.
Boenning & Scattergood first reported a position in AstraZeneca in Q2 2020 and has held it in 11 quarters since.
1,061 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2022.

Based on Boenning & Scattergood's 13F filing for Q4 2022, filed 26 Jan 2023.